MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Tau Network Genes in a Genome Wide Association Study of Progressive Supranuclear Palsy

    T. Chang (Los Angeles, CA, USA)

    Objective: To determine how tau network genes overlap with single nucleotide polymorphisms (SNPs) associated with Progressive Supranuclear Palsy (PSP) in a Genome Wide Association Study…
  • 2017 International Congress

    Parkinsonism in Patients with Alzheimer Disease and Epileptic Seizures

    I. Petrov (Skopje, The former Yugoslav Republic of Macedonia)

    Objective:  This article  present the specifics of the parkinsonism which is observed in patients with Alzheimer disease,diagnosed epilepileptic seizures,especially as a diferential diagnostic problem, followed for a…
  • 2017 International Congress

    Secondary Vascular Parkinsonism in Uzbekistan: Hormonal Pathogenetic Effects and Vascular-Immunological Basics.

    D. Akramova (Tashkent, Uzbekistan)

    Objective: We aimed to analyze the PD related hormonal factors and VP hormonal endothelial factors. Background: As we know the Vascular Parkinsonism (VP) and Symptomatic…
  • 2017 International Congress

    Levodopa induced dyskinesia in a case of progressive supranuclear palsy.

    T. Yamamoto, H. Kawasaki, T. Furuya, A. Miyake, T. Mitsufuji, T. Fukuoka, Y. Ito, Y. Nakazato, K. Takahashi, N. Tamura, N. Araki (Saitama, Japan)

    Objective: We describe the mechanism of dyskinesia in patients with progressive supranuclear palsy (PSP). Background: Levodopa generally shows a poor effect to parkinsonism in patients…
  • 2017 International Congress

    Aspects of Quality of Life in MSA and PSP

    L. Wiblin, M. Lee, D. Burn (Newcastle-upon-Tyne, United Kingdom)

    Objective: The aim of this study was exploring  the correlation between disease severity and QoL in PSP and MSA. Background: MSA and PSP are atypical Parkinsonian disorders that…
  • 2017 International Congress

    Perceived facilitators and barriers in communicating with family member among people with Parkinson’s Disease: A focus group study

    J. Lee, Y. Kim (Seoul, Republic of Korea)

    Objective: The purpose of this study was to identify perceived facilitators and barriers for better communication with family member among people with Parkinson’s disease (PD).…
  • 2017 International Congress

    From local partnership to national network: the growth of a medically connected, community based program model for Parkinson’s wellness

    A. Lemen, P. Schmidt, PhD, R. Hagestuen, RN, V. Edelson, C. Kohles, M. Donovan, T. Elkins, M. Sweeney, LMSW, A. DiRocco, MD (New York, NY, USA)

    Objective: To increase the scale of a medical and community partnership program model for the delivery of comprehensive Parkinson’s Wellness programming. Background: In 2007, an…
  • 2017 International Congress

    A Novel Deep Brain Stimulation Programming Paradigm for Essential Tremor

    J. Karl, L. Verhagen (Chicago, IL, USA)

    Objective: To report the outcome of a novel interleaving stimulation (interlink-ILS) DBS programming paradigm (PP). Background: DBS of the VIM is an effective treatment option…
  • 2017 International Congress

    Safe Functional MR Imaging in STN-DBS implanted Parkinson’s disease

    M. Saxena, C. McIntyre, B. Walter (Cleveland, OH, USA)

    Objective: Evaluation of clinically optimized settings in bilateral STN-DBS Parkinson’s disease, allows anatomical correlations with benefits and side effects. Background: MRI acquisition can cause permanent…
  • 2017 International Congress

    Effect of bilateral subthalamic nucleus deep brain stimulation on quality of life in advanced Parkinson’s disease patients

    s. tandra, B. ramavath, r.m. kandadai, r. borgohain (hyderabad, India)

    Objective: To evaluate the effect of bilateral subthalamic nucleus deep brain stimulation( STN DBS) on motor control, quality of life (QOL) and cognition in a cohort of…
  • « Previous Page
  • 1
  • …
  • 126
  • 127
  • 128
  • 129
  • 130
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley